Everything Isn’t as Perfect as It Seems in Ireland

By Lynn Webster, M.D. / May 19, 2018 /

Is the Opioid Crisis Uniquely an American Problem? For the past two weeks, I have been visiting Ireland. I attended a meeting for a few days in Dublin, but then my wife and I toured parts of the beautiful country boasting deeply green meadows that connected huge historic cathedrals and exquisite castles. On the way…

Yes, Restrictions on Opioids Are a Threat to Human Rights

By Lynn Webster, M.D. / May 12, 2018 /

Checking the Accuracy of a Story In a recent Washington Post story, “Are restrictions on opioids a threat to human rights?,” Charles Lane states that the wave of prescription opioid overdoses has crested thanks to public policy changes including the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain. Actually, opioid prescribing and overdoses essentially…

David C. Holzman Shatters Addiction Myths

By Lynn Webster, M.D. / May 5, 2018 /

Addiction Is a Complex Disease In a WBUR CommonHealth article, “How I Was Seduced By Cigarettes, And What Set Me Free,” David C. Holzman bravely recalled his struggle with the addiction of nicotine. He was honest enough to describe the stressors in his life that made him vulnerable to the addiction and the changes of…

Opioid Lawsuits Threaten Lives of Pain Sufferers

By Lynn Webster, M.D. / April 28, 2018 /

Implications for People With Chronic Pain Several lawsuits have been filed against several opioid manufacturers, distributors, and physicians for participating in what was allegedly a scheme to cause incalculable harm for profit. I am one of the physicians named as an alleged “conspirator.” The opioid lawsuits are far more than legal matters that involve the…

Utah Opioid Crisis Summit

By Lynn Webster, M.D. / April 21, 2018 /

University of Utah’s Summit Addressed State’s Opioid Problem On April 23, 2018, the University of Utah’s summit convened to discuss how to solve the state’s opioid problem. The summit’s goal was to identify barriers faced by health care providers and others in providing effective treatment of pain and addiction. The participants’ diverse professional backgrounds provided…

Repeating the Mistakes of the Past

By Lynn Webster, M.D. / April 14, 2018 /

I’m pleased to present a blog written by Megan Nalamachu who is a bright, articulate high school student. Her father, Dr. Srinivas Nalamachu, is a treasured colleague and friend. He proudly sent me his daughter’s well-researched work, because he believed I’d be interested in it. He was correct. Megan did a wonderful job rendering a…

Prescription Drug Advertisements

By Lynn Webster, M.D. / April 7, 2018 /

  Selling Prescription Drugs via Direct-to-Consumer Advertising “Next year, how about fewer ads that fuel opioid addiction and more on access to treatment,” White House Chief of Staff Denis McDonough complained on Twitter. “Was that really an ad for junkies who can’t [poop]? America, I luv ya but I just can’t keep up,” TV host…

Family of Pain

By Lynn Webster, M.D. / March 31, 2018 /

Failing to Understand the Experience of Pain Most people in pain do not like talking about their pain problem with others. When they do mention it to friends and family, they generally are disappointed at the responses. People are well intended, at least initially, but they can be insensitive. Fundamentally, they fail to understand what…

The ACPA Presents Programs for Migraine Sufferers

By Lynn Webster, M.D. / March 24, 2018 /

Migraine Awareness According to Penney Cowan, Founder and CEO of the Founder and CEO of the American Chronic Pain Association (ACPA), “More than 29.5 million Americans suffer from migraines, with women being affected three times more often than men.” Contrary to the popular misconception, a migraine isn’t just a severe headache. According to the ACPA,…

Black Box Warnings

By Lynn Webster, M.D. / March 17, 2018 /

  How Drugs Receive FDA Approval The Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) is the watchdog agency that’s responsible for testing new medications before they are approved. Drug manufacturers seek approval from the FDA after they have conducted numerous clinical trials and submitted all of their data to the…

Blog Subscription

Name(Required)

Archives

Categories